Search Results 141-150 of 11430 for ���������������������������:za33���24������ ������������������������ ������

  1. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study ACT16970 consists of 2 parts (A and B) as follows: Part A is a 24 week, double blind, placebo controlled part, preceded by a screening period of up to ...

  2. Publications - Zvonimir S. Katusic, M.D., Ph.D. - Mayo Clinic

    ... Z, Liang SC, Liu JTC, Luscher TF, Michel F ... Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga ... 2016 Jun 24; 80 (7):1499-503 Epub 2016 May 25

  3. Publications - Stacey A. Rizza, M.D. - Mayo Clinic

    ... Z, Vergidis P, Wilson JW, Cummins NW. ... Z, Vergidis P, Wilson JW, Cummins NW. Pharmacogenomic panel ... 2021 Jan 6; 21 (1):24 Epub 2021 Jan 06. View ...

  4. Publications - Ziad Zoghby, M.D., M.B.A. - Mayo Clinic

    Publications. Print. Mateo Chavez MB, Moran-Melendez A, Salter L, Vaughan L, Loor-Torres RJ, Albright R, Manohar S, Zoghby Z ... Zoghby Z. ... 2014 Dec 11; 371 (24): ...

  5. Clinical trials - Oncology (Medical)

    Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...

  6. News Releases

    June 24, 2025. Mayo Clinic in Arizona announces launch of new lung transplant program offering hope and restored function to patients facing advanced lung ...

  7. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-011889; Jacksonville, Florida: 24-011889. NCT ID: NCT06158841. Sponsor Protocol Number: M22-574. About this study. The purpose ...

  8. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

    ... 24:59-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/tests-procedures/cardiac-rehabilitation/multimedia/vid ...

  9. https://www.mayoclinic.org/chinese_organization_concepts.xml

    ... 24-05:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/departments-centers/cardiovascular-medicine/sections ...

  10. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303) - Mayo Clinic

    Jacksonville, Florida: 24-004302; Rochester, Minnesota: 24-004302; Scottsdale/Phoenix, Arizona: 24-004302. NCT ID: NCT06259552. Sponsor Protocol Number: PROT-CR ...